Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

5 Best- And Worst-Performing Mega-Cap Stocks In July 2022

Published 08/02/2022, 01:00 AM
Updated 05/14/2017, 06:45 AM

After a dismal performance in the first six months of 2022, July offered some respite for stock market investors. In fact, July has been the best month for the S&P 500 since November 2020. The index gained more than 9% last month, and all of the top mega-cap stocks offered decent returns to investors. Let’s take a look at the five best- and worst-performing mega-cap stocks in July 2022.

The Five Best-Performing Mega-Cap Stocks In July 2022

We have used the July return data for mega-cap stocks from finviz.com to rank the five best- and worst-performing mega-cap stocks in July 2022. Let’s start with the five best-performing mega-cap stocks in July 2022:

5. Danaher (15%)

Founded in 1984 and headquartered in Washington, D.C., Danaher (NYSE:DHR) is a medical company that develops professional, medical, industrial, and commercial products and services. The shares have lost almost 12% year to date and are down more than 2% in the last year. As of the time of this writing, the company's shares are trading at more than $290. They have a 52-week range of $233.71 to $333.96. Danaher reported more than $29 billion in revenue for 2021 and over $22 billion in 2020.

4. Apple (17%)

Founded in 1976 and headquartered in Cupertino, California, Apple (NASDAQ:AAPL) develops and sells smartphones, tablets, wearables, computers, and related services and software. The shares have lost more than 8% year to date but are up by almost 12% in the last year. As of the time of this writing, it is trading at above $162, and their 52-week range is $129.04 to $182.94. Apple reported more than $360 billion in revenue for 2021 and over $270 billion in 2020.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

3. NVIDIA (17%)

Founded in 1993 and headquartered in Santa Clara, California, NVIDIA (NASDAQ:NVDA) is a computing platform company that develops graphics-processor technologies for workstations, desktop computers, and mobile devices. The shares have lost almost 36% year to date and are down by over 7% in the last year. As of the time of this writing, the chipmaker's shares are trading at above $184 with a 52-week range of $140.55 to $346.47. NVIDIA reported more than $26 billion in revenue for 2021 and over $16 billion in 2020.

2. Amazon (24%)

Founded in 1994 and headquartered in Seattle, Washington, Amazon (NASDAQ:AMZN) is an e-commerce company that also serves developers and enterprises through Amazon Web Services. The shares have lost more than 18% year to date and are down by almost 18% in the last year. As of the time of this writing, the company's shares are trading at above $136, and their 52-week range is $101.26 to $188.11. Amazon reported more than $460 billion in revenue for 2021 and over $380 billion in 2020.

1. Tesla (30%)

Founded in 2003 and headquartered in Austin, Texas, Tesla (NASDAQ:TSLA) develops and sells fully electric vehicles and energy generation and storage systems. The shares have lost almost 13% year to date but have gained almost 30% in the last year. As of the time of this writing, the company's shares are trading at above $923 with a 52-week range of $620.57 to $1,243.49. Tesla reported more than $53 billion in revenue for 2021 and over $31 billion in 2020.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Five Worst-Performing Mega-Cap Stocks In July 2022

Here are the five worst-performing mega-cap stocks in July 2022:

5. Johnson & Johnson (-1%)

Founded in 1886 and headquartered in Brunswick, New Jersey Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products. The shares have gained almost 2% year to date and are up by almost 1% in the last year. As of the time of this writing, it is trading at above $173 with a 52-week range of $155.72 to $186.69. Johnson & Johnson reported more than $90 billion in revenue for 2021 and over $80 billion in 2020.

4. Procter & Gamble (-2%)

Founded in 1837 and headquartered in Cincinnati, Ohio, Procter & Gamble (NYSE:PG) is a consumer goods company that offers products and services for various rooms, including kitchens, laundry rooms, bathrooms and more. The shares have lost almost 14% year to date and are down by almost 1% in the last year. As of the time of this writing, it is trading at above $140 with a 52-week range of $129.50 to $165.35. Procter & Gamble reported more than $76 billion in revenue for 2021 and over $70 billion in 2020.

3. Meta Platforms (-3%)

Founded in 2004 and headquartered in Menlo Park, California, Meta Platforms (NASDAQ:META) develops and operates social media apps. The shares have lost more than 52% year to date and are down by almost 55% in the last year. As of the time of this writing, it is trading at above $159 with a 52-week range of $154.25 to $384.33. Meta Platforms reported more than $110 billion in revenue for 2021 and over $80 billion in 2020.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

2. Merck & Co. (-3%)

Founded in 1891 and headquartered in Kenilworth, New Jersey, Merck (NYSE:MRK) offers health solutions through its prescription medicines, animal health products, vaccines, biologic therapies and consumer care product lines. The shares have gained almost 16% year to date and are up by over 16% in the last year. As of the time of this writing, it is trading at above $88 with a 52-week range of $70.89 to $95.72. Merck reported more than $48 billion in revenue for 2021 and over $41 billion in 2020.

1. AbbVie (-7%)

Founded in 2011 and headquartered in North Chicago, Illinois, AbbVie (NYSE:ABBV) is a biopharmaceutical company that focuses on developing and selling pharmaceutical products that treat conditions such as chronic autoimmune diseases. The shares have gained more than 4% year to date and are up by over 22% in the last year. As of the time of this writing, the company's shares are trading at above $140 with a 52-week range of $105.56 to $175.91. AbbVie reported more than $56 billion in revenue for 2021 and over $45 billion in 2020.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.